STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

SMMT SUMMIT THERAPEUTICS INCORPORATED StockScouter® Report

1

StockScouter® Score

SUMMIT THERAPEUTICS INCORPORATED, a mid cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Moving average analysis for SMMT suggests strong price movement over the medium term. Positive

 

Concerns

  • Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
  • One or more analysts has modestly decreased quarterly earnings estimates for SMMT. Negative
  • Short-term relative price momentum exhibits meaningful weakness. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 100% done.
Progress: 40% done.
Low
High

Core Model Grades

D
C
N/A
C

Previous Ratings

2
1
1